✨ Medicines Distribution Consents
3396 NEW ZEALAND GAZETTE No. 126
Product:
Macleans Ice Advanced Whitening
Active Ingredient:
Sodium fluoride 0.221%w/w
Dosage Form:
Toothpaste
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Australia Pty Limited, Ermington, New South Wales, Australia
Dated this 31st day of August 2003.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).
go5845
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Nurofen Caplet
Active Ingredient:
Ibuprofen 200mg
Dosage Form:
Coated tablet
New Zealand Sponsor:
Boots Healthcare New Zealand Limited
Manufacturer:
The Boots Company Plc, Beeston, Nottingham, United Kingdom
Product:
Nurofen
Active Ingredient:
Ibuprofen 200mg
Dosage Form:
Coated tablet
New Zealand Sponsor:
Boots Healthcare New Zealand Limited
Manufacturer:
The Boots Company Plc, Beeston, Nottingham, United Kingdom
Product:
Quadracel
Active Ingredients:
Adsorbed tetanus vaccine 5Lf U
Diphtheria toxoid, adsorbed 15Lf U
Pertactin 3µg
Pertussis filamentous haemagglutinin 20µg
Pertussis fimbriae 2+3 5µg
Pertussis toxoid, adsorbed 20µg
Polio virus type 1 40DAgU
Polio virus type 2 8DAgU
Polio virus type 3 32DAgU
Dosage Form:
Suspension for injection
New Zealand Sponsor:
Aventis Pharma Limited
Manufacturer:
Aventis Pasteur Limited, North York, Ontario, Canada
Dated this 31st day of August 2003.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).
go5844
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Dysport
Active Ingredient:
Clostridium botulinum type A toxin haemagglutinin complex 500U
Dosage Form:
Powder for injection
New Zealand Sponsor:
New Zealand Medical & Scientific Limited
Manufacturer:
Ispen Limited, Clwyd, United Kingdom
Product:
Lescol XL
Active Ingredient:
Fluvastatin sodium 84.24mg equivalent to 80mg fluvastatin
Dosage Form:
Modified release tablet
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Novartis Pharma Stein AG, Stein, Switzerland
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2003, No 126
Gazette.govt.nz —
NZ Gazette 2003, No 126
✨ LLM interpretation of page content
🏥 Consent to the Distribution of New Related Products
🏥 Health & Social Welfare31 August 2003
Medicines, Distribution, Medicines Act 1981, Macleans Ice Advanced Whitening
- DON MATHESON, Deputy Director-General, Public Health
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare31 August 2003
Medicines, Distribution, Medicines Act 1981, Nurofen, Quadracel
- DON MATHESON, Deputy Director-General, Public Health
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social Welfare31 August 2003
Medicines, Distribution, Medicines Act 1981, Dysport, Lescol XL
- DON MATHESON, Deputy Director-General, Public Health